Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_assertion type Assertion NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_head.
- NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_assertion description "[We have used SKY for comprehensive analysis of 20 myelodysplastic syndromes (MDSs) (13 primary MDSs, 3 therapy-related MDSs, and 4 acute leukemias developed from MDS, including 1 cell line established from a secondary leukemia), previously analyzed by G-banding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_provenance.
- NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_assertion evidence source_evidence_literature NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_provenance.
- NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_assertion SIO_000772 10534769 NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_provenance.
- NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_assertion wasDerivedFrom befree-20150227 NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_provenance.
- NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_assertion wasGeneratedBy ECO_0000203 NP873306.RABAwNwnQnpiotCAVSY_co2DP63TqA-YZ8e67BeP4XMRY130_provenance.